What is the catalog number for Alpha Synuclein Pre-formed Fibrils: Biotinylated?

The catalog number for Alpha Synuclein Pre-formed Fibrils: Biotinylated is SPR-508XE.

What sizes are available for Alpha Synuclein Pre-formed Fibrils: Biotinylated?

Alpha Synuclein Pre-formed Fibrils: Biotinylated is available in the following size(s): 500 µg (@ 5 mg/mL).

Is Alpha Synuclein Pre-formed Fibrils: Biotinylated in stock?

Alpha Synuclein Pre-formed Fibrils: Biotinylated is currently made to order / not held in immediate stock. Contact us for lead time.

Are there any special shipping requirements for Alpha Synuclein Pre-formed Fibrils: Biotinylated?

Alpha Synuclein Pre-formed Fibrils: Biotinylated is requires dry ice shipping.

Where can I find the safety data sheet (SDS/MSDS) for Alpha Synuclein Pre-formed Fibrils: Biotinylated?

The safety data sheet for Alpha Synuclein Pre-formed Fibrils: Biotinylated is available here: https://cdn.gentaur.com/products/400/8945092280954/msds/spr-508xe.pdf.

Alpha Synuclein Pre-formed Fibrils: Biotinylated

Human Recombinant Alpha Synuclein PFFs: Biotinylated (C-terminus)

Product Specifications

Background

A 15 amino acid tag on the C-terminal tail of Alpha Synuclein facilitates site-specific covalent biotinylation (1) . Biotinylation of purified alpha synuclein allows for many biological applications, such as monitoring and detection using streptavidin-based conjugates (1, 2, 3) . Our biotinylated monomers are also used to generate pre-formed fibrils in-vitro.

Product Name Alternative

Alpha synuclein, Alpha-synuclein pre-formed fibril, Alpha synuclein protein PFF, Alpha synuclein PFF, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, SYN protein, Parkinson disease familial 1 Protein

UNSPSC

12352202

UN Code

Non-hazardous

Hazard Statement

Non-hazardous

Swiss Prot

P37840

Expression System

E. coli

Host

E. coli

Origin Species

Human

Target

Alpha Synuclein Biotinylated (C-terminus)

Conjugation

C-terminal 15 amino acid tag: biotinylated

Nature

Recombinant

Sequence

MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVH GVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQL GKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEAGLNDIFEAQK IEWHE

Applications

WB | SDS PAGE | In vitro Assay | In vivo Assay

Field of Research

Purification Method

Ion-exchange Purified

Purification

Ion-exchange Purified

Limit Of Detection

Protein certified > 95% pure via SDS-PAGE and nanodrop analysis. Low endotoxin (< 5 EU/mL) at 2 mg/mL.

Concentration

2 mg/ml or 5 mg/ml

Purity

>95% based on SDS-PAGE and nanodrop analysis.

Weight

0.05

Length

155 aa

Buffer

PBS pH 7.4

Molecular Weight

16.27 kDa

Precautions

Not for use in humans. Not for use in diagnostics or therapeutics. For research use only.

Additionnal Information

For best results, sonicate immediately prior to use. Refer to the Neurodegenerative Protein Handling Instructions on our website, or the product datasheet for further information.

References & Citations

1. Fairhead & Howarth. 2015. Site-specific biotinylation of purified proteins using BirA. Methods in Molecular Biology. DOI: 1007/978-1-4939-2272-7_12 2. Hallacli et al. 2022. The Parkinson’s disease protein alpha synuclein is a modulator of Processing-bodies and mRNA stability. Cell. DOI: 10.1016/j.cell.2022.05.008 3. Li et al. 2019. Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Acta neuropathologica. DOI: 10.1007/s00401-019-01974-5.

Shipping Conditions

Dry Ice. Shipping note: Product will be shipped separately from other products purchased in the same order.

Storage Conditions

-80ºC

Notes

For best results, sonicate immediately prior to use. Refer to the Neurodegenerative Protein Handling Instructions on our website, or the product datasheet for further information.

Protein Length

155 aa

Background Reference 01

AA Sequence

MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVH GVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQL GKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEAGLNDIFEAQK IEWHE